Atrial Arrhythmia
Conditions
Keywords
Reply, Symphony, Atrial arrhythmias, V pacing, Evaluate the incidence and evolution over-time of co-morbidities
Brief summary
The purpose of this study is to evaluate the incidence and evolution over-time of co-morbidities in a general dual-chamber pacemaker population (n=2188 patients) through a 2 years follow-up.
Detailed description
The study will focus on the number of patients moving to persistent Atrial Fibrillation as a function of cumulative %Vp (\< or \>40%), in a general dual-chamber pacemaker population through a 2 year follow-up (n=2188). The same endpoint will be analyzed in sub populations (Sinus Node Disease and AVB) at 4 years follow up (n=4290).
Interventions
None listed
Sponsors
MicroPort CRM
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
\- Patient implanted (primo-implant, replacement, upgrade) with dual chamber pacemaker from less than two months or implanted at inclusion.
Exclusion criteria
* Contraindicated for cardiac pacing, according to the ESC and ACC/AHA/HRS guidelines * Permanent or persistent atrial tachyarrhythmia
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Atrial arrhythmias incidence | 2 years | Two consecutive visits in which atrial fibrillation was present or - at least 22 hours of atrial fibrillation for at least 7 consecutive days or - at least 22 hours of atrial fibrillation per day for fewer than 7 consecutive days if an interruption by electrical or pharmacologic cardioversion occurred |
| % ventricular pacing | 2 years | as measured in the device over the timeframe period |
Countries
Australia, Belgium, Canada, Denmark, France, Germany, Italy, Japan, Netherlands, Spain, Switzerland, United States
Outcome results
None listed